Oncology

Innovation

"Our Goal Is to Prevent Lung Cancer from Happening in the First Place"

Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Lung Cancer Awareness Month, Johnson & Johnson researchers share the progress that's being made to thwart the #1 cancer killer.

ON NOW

Innovation

The Next Frontier of Prostate Cancer Care

Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That's why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.

ON NOW

Innovation

The Latest Science Behind Caring for Your Skin While on Chemotherapy

Most people know about side effects, like hair loss, that can accompany cancer treatment. But chemotherapy can also impact your skin. Oncodermatologists and Johnson & Johnson scientists looked into how to care for such skin—leading to a new science-backed line of cleansers, moisturizers and balms designed with cancer patients in mind.

ON NOW

Innovation

4 Ways Johnson & Johnson Is Cultivating Outside-the-Box Innovations for COVID-19

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

ON NOW

Latest News

Cancer Scientist Lewis Cantley, Ph.D., Wins the 2020 Dr. Paul Janssen Award for Biomedical Research

Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.

ON NOW

Innovation

Meet the Man Who's Taking On the Emperor of All Maladies: Cancer

Siddhartha Mukherjee, M.D., made his name as an oncologist, researcher and Pulitzer Prize-winning writer. Now he's the scientific adviser of an immuno-oncology start-up that's tackling a rare form of leukemia. In an exclusive interview, he reveals his vision for the future of cancer treatments.

ON NOW

A graphic of a close-up view of bladder cancer

Innovation

From Aha! Moment to FDA Approval: The Fascinating Story Behind a New Treatment for Bladder Cancer

We retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of the disease to patients who may benefit most.

ON NOW

Innovation

Lung Cancer: What You Need to Know About Your Risk Factor—Even if You've Never Smoked

Some 20% of people diagnosed with the disease haven't touched a cigarette. For Healthy Lung Month, scientists who've dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.

ON NOW

Innovation

New Year, New Vision: Meet a Man Tasked With Investing in What Could Be the World's Next Great Medical Discoveries

Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson's venture capital division, which invests in dozens of companies each year. He shares what's on his radar for 2019.

ON NOW

Caring & Giving

Caring & Giving Around the Globe: 43 Johnson & Johnson Programs That Are Transforming Lives—and the Future of Healthcare

43 Johnson & Johnson Programs Around the World That Are Transforming Lives—and the Future of Healthcare

Check out this fun interactive map for a glimpse at how the company is helping people on nearly every continent live healthier lives.

ON NOW

Pierre Theodore, M.D., volunteering at a hospital in Haiti

Personal Stories

Doing Good Day and Night: 6 Johnson & Johnson Employees Who Are Making the World a Better Place

Who says you can't take your work home with you? For these men and women, their day jobs are just one facet of living a purpose-driven life to help others in truly impactful ways.

ON NOW

Innovation

How Johnson & Johnson Is Pioneering in the Fight Against the World's #1 Cancer Killer

The doctor overseeing the company's new Lung Cancer Initiative reveals why it's uniquely qualified to work on thwarting the disease—and why he's uniquely qualified to oversee its efforts.

ON NOW

Sen Zhuang, M.D., Ph.D., Vice President, Oncology Clinical Research, Janssen Research & Development

Innovation

4 Questions for a Scientist Working on a Revolutionary CAR-T Therapy for Multiple Myeloma

Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.

ON NOW

Internet Explorer is no longer supported by this website.

Oncology